Search results
Author(s):
Chris Wai Hang Lo
,
Yue Fei
,
Bernard Man Yung Cheung
Added:
3 years ago
Author(s):
Anjali Agarwalla
,
Jadry Gruen
,
Carli Peters
,
et al
Added:
2 years ago
Author(s):
Mary-Tiffany Oduah
,
Varun Sundaram
,
Yogesh Reddy
Added:
11 months ago
Author(s):
Thomas G von Lueder
,
Dipak Kotecha
,
Dan Atar
,
et al
Added:
3 years ago
Heart Failure (HF) constitutes a major global health problem, evidenced by substantial morbidity and mortality, requiring enormous healthcare-related expenditure. HF is associated with high symptomatic burden, and with a relentless and progressive clinical course towards end-stage disease. A large body of epidemiological data suggests that the prognosis in HF is as poor as in advanced cancer.1…
View more
Author(s):
Jelena Celutkiene
,
Mindaugas Balčiūnas
,
Denis Kablučko
,
et al
Added:
3 years ago
Heart failure (HF) and chronic obstructive pulmonary disease (COPD) comorbidity poses substantial diagnostic and therapeutic challenges in acute care settings. Outcomes of this comorbidity are worse than in either disease alone.1,2 A hospital diagnosis of COPD is an independent predictor of all-cause and non-cardiovascular mortality in HF patients,3–5 associated with decrease in use of evidence…
View more
Author(s):
Tobias Koenig
,
Johann Bauersachs
,
Denise Hilfiker-Kleiner
Added:
3 years ago
Cardiovascular diseases (CVD) are a major cause of complications in pregnancies worldwide, and can be largely attributed to increased cardiovascular risk factors, such as obesity and hypertensive disorders.1 Today, up to 4% of all pregnancies are complicated by CVD, with increasing frequency.2 Cardiomyopathies – whether inherited or acquired – represent the leading cause of maternal morbidity and…
View more
Author(s):
Bao Tran
,
Gregg C Fonarow
Added:
3 years ago
Heart failure (HF) remains a major public health problem resulting in substantial morbidity, mortality and healthcare expenditures globally. The European Society of Cardiology (ESC) 2012 Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure and the American College of Cardiology Foundation (ACCF)/American Heart Association (AHA) 2013 Guideline for the Management of Heart…
View more
Author(s):
Ovidiu Chioncel
,
Sean P Collins
,
Andrew P Ambrosy
,
et al
Added:
3 years ago
Acute heart failure (AHF) is a heterogeneous clinical syndrome including diverse phenotypes sharing similar presenting signs and symptoms.1 The diversity of aetiologies and precipitants of HF and their specific pathophysiologic mechanisms, may result in distinct clinical profiles requiring specific treatment approaches.
Pulmonary oedema (PO) is a common manifestation of AHF associated with a…
View more
Levosimendan Efficacy and Safety
Author(s):
Zoltán Papp
,
Piergiuseppe Agostoni
,
Julian Alvarez
,
et al
Added:
3 years ago
Article
Author(s):
Joe Gallagher
,
Chris Watson
,
Patricia Campbell
,
et al
Added:
3 years ago
Increasingly biomarkers are of interest in cardiovascular disease (CVD) for risk stratification. In particular, natriuretic peptides (NPs), which were originally used for the diagnosis of heart failure, are now finding a role in identifying those most at risk of heart failure and other cardiovascular (CV) disorders. Their ability to be measured rapidly through blood tests makes their widespread…
View more